790 related articles for article (PubMed ID: 28534875)
1. Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial.
Quintana DS; Westlye LT; Hope S; Nærland T; Elvsåshagen T; Dørum E; Rustan Ø; Valstad M; Rezvaya L; Lishaugen H; Stensønes E; Yaqub S; Smerud KT; Mahmoud RA; Djupesland PG; Andreassen OA
Transl Psychiatry; 2017 May; 7(5):e1136. PubMed ID: 28534875
[TBL] [Abstract][Full Text] [Related]
2. Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment.
Quintana DS; Westlye LT; Rustan ØG; Tesli N; Poppy CL; Smevik H; Tesli M; Røine M; Mahmoud RA; Smerud KT; Djupesland PG; Andreassen OA
Transl Psychiatry; 2015 Jul; 5(7):e602. PubMed ID: 26171983
[TBL] [Abstract][Full Text] [Related]
3. Low dose intranasal oxytocin delivered with Breath Powered device dampens amygdala response to emotional stimuli: A peripheral effect-controlled within-subjects randomized dose-response fMRI trial.
Quintana DS; Westlye LT; Alnæs D; Rustan ØG; Kaufmann T; Smerud KT; Mahmoud RA; Djupesland PG; Andreassen OA
Psychoneuroendocrinology; 2016 Jul; 69():180-8. PubMed ID: 27107209
[TBL] [Abstract][Full Text] [Related]
4. Oxytocin improves behavioural and neural deficits in inferring others' social emotions in autism.
Aoki Y; Yahata N; Watanabe T; Takano Y; Kawakubo Y; Kuwabara H; Iwashiro N; Natsubori T; Inoue H; Suga M; Takao H; Sasaki H; Gonoi W; Kunimatsu A; Kasai K; Yamasue H
Brain; 2014 Nov; 137(Pt 11):3073-86. PubMed ID: 25149412
[TBL] [Abstract][Full Text] [Related]
5. Restoring effects of oxytocin on the attentional preference for faces in autism.
Kanat M; Spenthof I; Riedel A; van Elst LT; Heinrichs M; Domes G
Transl Psychiatry; 2017 Apr; 7(4):e1097. PubMed ID: 28418399
[TBL] [Abstract][Full Text] [Related]
6. Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism.
Watanabe T; Kuroda M; Kuwabara H; Aoki Y; Iwashiro N; Tatsunobu N; Takao H; Nippashi Y; Kawakubo Y; Kunimatsu A; Kasai K; Yamasue H
Brain; 2015 Nov; 138(Pt 11):3400-12. PubMed ID: 26336909
[TBL] [Abstract][Full Text] [Related]
7. Low-dose intranasal oxytocin delivered with Breath Powered device modulates pupil diameter and amygdala activity: a randomized controlled pupillometry and fMRI study.
Quintana DS; Westlye LT; Alnæs D; Kaufmann T; Mahmoud RA; Smerud KT; Djupesland PG; Andreassen OA
Neuropsychopharmacology; 2019 Jan; 44(2):306-313. PubMed ID: 30323359
[TBL] [Abstract][Full Text] [Related]
8. Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity: a randomized trial.
Watanabe T; Abe O; Kuwabara H; Yahata N; Takano Y; Iwashiro N; Natsubori T; Aoki Y; Takao H; Kawakubo Y; Kamio Y; Kato N; Miyashita Y; Kasai K; Yamasue H
JAMA Psychiatry; 2014 Feb; 71(2):166-75. PubMed ID: 24352377
[TBL] [Abstract][Full Text] [Related]
9. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial.
Guastella AJ; Gray KM; Rinehart NJ; Alvares GA; Tonge BJ; Hickie IB; Keating CM; Cacciotti-Saija C; Einfeld SL
J Child Psychol Psychiatry; 2015 Apr; 56(4):444-52. PubMed ID: 25087908
[TBL] [Abstract][Full Text] [Related]
10. Do blood plasma levels of oxytocin moderate the effect of nasally administered oxytocin on social orienting in high-functioning male adults with autism spectrum disorder?
Althaus M; Groen Y; A Wijers A; Noltes H; Tucha O; Sweep FC; Calcagnoli F; Hoekstra PJ
Psychopharmacology (Berl); 2016 Jul; 233(14):2737-51. PubMed ID: 27256356
[TBL] [Abstract][Full Text] [Related]
11. Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial.
Yamasue H; Okada T; Munesue T; Kuroda M; Fujioka T; Uno Y; Matsumoto K; Kuwabara H; Mori D; Okamoto Y; Yoshimura Y; Kawakubo Y; Arioka Y; Kojima M; Yuhi T; Owada K; Yassin W; Kushima I; Benner S; Ogawa N; Eriguchi Y; Kawano N; Uemura Y; Yamamoto M; Kano Y; Kasai K; Higashida H; Ozaki N; Kosaka H
Mol Psychiatry; 2020 Aug; 25(8):1849-1858. PubMed ID: 29955161
[TBL] [Abstract][Full Text] [Related]
12. Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial.
Kosaka H; Okamoto Y; Munesue T; Yamasue H; Inohara K; Fujioka T; Anme T; Orisaka M; Ishitobi M; Jung M; Fujisawa TX; Tanaka S; Arai S; Asano M; Saito DN; Sadato N; Tomoda A; Omori M; Sato M; Okazawa H; Higashida H; Wada Y
Transl Psychiatry; 2016 Aug; 6(8):e872. PubMed ID: 27552585
[TBL] [Abstract][Full Text] [Related]
13. Oxytocin-induced increase in N,N-dimethylglycine and time course of changes in oxytocin efficacy for autism social core symptoms.
Kato Y; Kuwabara H; Okada T; Munesue T; Benner S; Kuroda M; Kojima M; Yassin W; Eriguchi Y; Kameno Y; Murayama C; Nishimura T; Tsuchiya K; Kasai K; Ozaki N; Kosaka H; Yamasue H
Mol Autism; 2021 Feb; 12(1):15. PubMed ID: 33622389
[TBL] [Abstract][Full Text] [Related]
14. Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial.
Daniels N; Moerkerke M; Steyaert J; Bamps A; Debbaut E; Prinsen J; Tang T; Van der Donck S; Boets B; Alaerts K
Mol Autism; 2023 Apr; 14(1):16. PubMed ID: 37081454
[TBL] [Abstract][Full Text] [Related]
15. Does oxytocin lead to emotional interference during a working memory paradigm?
Tollenaar MS; Ruissen M; Elzinga BM; de Bruijn ERA
Psychopharmacology (Berl); 2017 Dec; 234(23-24):3467-3474. PubMed ID: 28913643
[TBL] [Abstract][Full Text] [Related]
16. Quantitative facial expression analysis revealed the efficacy and time course of oxytocin in autism.
Owada K; Okada T; Munesue T; Kuroda M; Fujioka T; Uno Y; Matsumoto K; Kuwabara H; Mori D; Okamoto Y; Yoshimura Y; Kawakubo Y; Arioka Y; Kojima M; Yuhi T; Yassin W; Kushima I; Benner S; Ogawa N; Kawano N; Eriguchi Y; Uemura Y; Yamamoto M; Kano Y; Kasai K; Higashida H; Ozaki N; Kosaka H; Yamasue H
Brain; 2019 Jul; 142(7):2127-2136. PubMed ID: 31096266
[TBL] [Abstract][Full Text] [Related]
17. The effect of intranasal oxytocin on perceiving and understanding emotion on the Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT).
Cardoso C; Ellenbogen MA; Linnen AM
Emotion; 2014 Feb; 14(1):43-50. PubMed ID: 24188065
[TBL] [Abstract][Full Text] [Related]
18. The effect of intranasal administration of oxytocin on fear recognition.
Fischer-Shofty M; Shamay-Tsoory SG; Harari H; Levkovitz Y
Neuropsychologia; 2010 Jan; 48(1):179-84. PubMed ID: 19747930
[TBL] [Abstract][Full Text] [Related]
19. Neural modulation of social reinforcement learning by intranasal oxytocin in male adults with high-functioning autism spectrum disorder: a randomized trial.
Kruppa JA; Gossen A; Oberwelland Weiß E; Kohls G; Großheinrich N; Cholemkery H; Freitag CM; Karges W; Wölfle E; Sinzig J; Fink GR; Herpertz-Dahlmann B; Konrad K; Schulte-Rüther M
Neuropsychopharmacology; 2019 Mar; 44(4):749-756. PubMed ID: 30390065
[TBL] [Abstract][Full Text] [Related]
20. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.
Guastella AJ; Einfeld SL; Gray KM; Rinehart NJ; Tonge BJ; Lambert TJ; Hickie IB
Biol Psychiatry; 2010 Apr; 67(7):692-4. PubMed ID: 19897177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
